Navigation Links
Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
Date:4/21/2008

BATON ROUGE, La., April 21 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report today on medicines in the research pipeline. The report found America's pharmaceutical research companies are testing a record 750 new medicines to help treat cancer.

"We released this report in Baton Rouge because of its particular relevance to the health of the population in Louisiana," says PhRMA Senior Vice President Ken Johnson. The report was unveiled at the State Capitol Building. "According to the Centers for Disease Control and Prevention, Louisiana has the highest death rate from cancer in the United States. In fact, recent data from the American Cancer Society tells us that African American men in Louisiana have the highest death rate and shortest survival rate in the country for all cancers combined, which is why we are releasing this report here to coincide with National Cancer Minority Awareness Week."

The medicines in the report are being tested in human clinical trials or are awaiting approval by the U.S. Food and Drug Administration.

"The medicines now in the research pipeline will add to the substantial progress made in the last five years by biopharmaceutical companies in developing new and more effective cancer treatments," notes PhRMA President and CEO Billy Tauzin. "This strong commitment to research is a product of the determination of the men and women working for America's pharmaceutical research companies to develop new medicines that will enable patients to live longer, healthier, and more productive lives. I am one of those patients who was diagnosed with cancer and was given a new treatment that brought me from the brink of death back to life."

Cancer medicines being developed include 113 for lung cancer, the leading cause of cancer death in the United States; 90 for breast cancer, which is expected to strike more than 180,000 American women this year; 65
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis
2. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
3. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
4. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
5. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
6. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
7. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
8. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
9. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
10. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  According to their CEO, Rob Bohacs ... is going through a complete transformation with highly ... the current clinical trial management process isn,t configured ... trials, which will ultimately drive the prescription cancer ... has been recognized by the National Cancer Institute as ...
(Date:9/30/2014)... 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... advance from Hercules Technology Growth Capital, Inc. (NYSE: ... and final advance under the Loan and Security Agreement ... , Alimera Sciences Limited, entered into with Hercules ...
(Date:9/30/2014)... -- A study using a relatively new imaging tool, ... the composition of carotid artery disease and has the ... disease, a leading cause of stroke. ... 2010 and May 2012, was featured in the June ... College of Cardiology (JACC) Cardiovascular Interventions. Interventional cardiologist ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... 21, 2012 InterMune, Inc. (NASDAQ: ITMN ... agreement with Vidara Therapeutics International Limited (Vidara) to sell ... transaction valued at $55 million plus a two-year royalty ... group of companies with operations in Ireland and the ...
... 2012  Consumers Union, the policy and advocacy arm of Consumer Reports, ... patients at risk in a full-page print ad in ... vote on a bill this week to reauthorize the statute governing ... that the FDA does not have the power under current law ...
Cached Medicine Technology:InterMune to Divest Actimmune® (Interferon Gamma-1b) 2InterMune to Divest Actimmune® (Interferon Gamma-1b) 3Dangerous Medical Device Loophole Puts Patients At Risk 2Dangerous Medical Device Loophole Puts Patients At Risk 3
(Date:10/1/2014)... co-funded by the Engineering and Physical Sciences Research ... the UK,s vital industrial control systems which run, ... grid, and the rail network. , The ... hackers or malware infiltrating the systems behind our ... in Trustworthy Industrial Control Systems (RITICS), based at ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new ... retired couples. , Senior citizens can purchase a ... their loved ones. A joint policy is cheaper, but ... away. , Life insurance can be used to ... even be purchased online, as the application process is ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 Beverly ... Dr. Kathleen Mojas is celebrating 20 years of private ... assisted hundreds of people to achieve greater joy and ... important list of warning signs and suggestions for anyone ... Dr. Mojas explains: “Believe it or not, it’s ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2
... Calif., Jan. 15 Abaxis, Inc.,(Nasdaq: ABAX ... systems, announced today that Clint Severson, CEO and,President, ... Company Emerging,Growth Conference on Wednesday, January 23, 2008 ... at The Ritz-Carlton, Palm Beach Florida., About ...
... incidence of liver cancer continues to grow-- fueled in large ... too does the need for tests to help diagnose the ... in the January 15 issue of Clinical Cancer Research demonstrates ... more accurate than traditional biomarkers in distinguishing liver cancer patients ...
... 14 Access,Pharmaceuticals, Inc. (OTC Bulletin Board: ... pharmaceutical company focused on bringing,proprietary medicines to ... of a,definitive licensing agreement under which RHEI, ... penetrating large volume hospitals, will,market Access,s proprietary ...
... MINRAD,International, Inc. (Amex: BUF ) today announced the ... Jr. as the new Chief,Financial Officer and Executive Vice ... from Hardinge, Inc., where he has been the,Chief Financial ... he served as the Chief Financial Officer and Treasurer ...
... American Physical Therapy Association Sponsors National Toll-Free,Hotline Addressing Ways ... ALEXANDRIA, Va., Jan. 14 Falls are,prevalent, dangerous, and ... nearly one in two seniors over age 80, will ... consequences.* As our nation,s population,ages, the rate of falls ...
... 14 The Lake Forest Hospital,Foundation board of directors ... create a new health care system for northeastern Illinois,and ... by a,combination of both hospital boards and would bring ... consumer ranked hospitals in,Lake County.*, As part of ...
Cached Medicine News:Health News:Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 2Health News:Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 3Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 2Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 3Health News:MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP 2Health News:MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP 3Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 2Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 3Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 4Health News:Lake Forest Hospital Proposes a New Health Care System in Lake County 2
... The Vasotrax is an ... pressure and heart rate non-invasively, ... fact, significantly more accurate than ... On a full battery charge, ...
... are heterodimeric proteins that suppress the secretion ... pituitary. Inhibin consists of two distinct chains, ... Inhibin A consists of the alpha-subunit and ... and betaB-subunit. Only the dimeric forms of ...
... (IGF-II) is a 7.5 kDa peptide which is ... to have mitogenic and metabolic actions involved in ... by binding to target cell receptors. IGF-II binds ... receptor, a monomeric protein which also serves as ...
... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
Medicine Products: